BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 22179672)

  • 1. Identification of HBsAg-specific antibodies from a mammalian cell displayed full-length human antibody library of healthy immunized donor.
    Li CZ; Liang ZK; Chen ZR; Lou HB; Zhou Y; Zhang ZH; Yu F; Liu S; Zhou Y; Wu S; Zheng W; Tan W; Jiang S; Zhou C
    Cell Mol Immunol; 2012 Mar; 9(2):184-90. PubMed ID: 22179672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New broadly reactive neutralizing antibodies against hepatitis B virus surface antigen.
    Kucinskaite-Kodze I; Pleckaityte M; Bremer CM; Seiz PL; Zilnyte M; Bulavaite A; Mickiene G; Zvirblis G; Sasnauskas K; Glebe D; Zvirbliene A
    Virus Res; 2016 Jan; 211():209-21. PubMed ID: 26541316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An hepatitis B virus surface antigen specific single chain of variable fragment derived from a natural immune antigen binding fragment phage display library is specifically internalized by HepG2.2.15 cells.
    Wen WH; Qin WJ; Gao H; Zhao J; Jia LT; Liao QH; Meng YL; Jin BQ; Yao LB; Chen SY; Yang AG
    J Viral Hepat; 2007 Jul; 14(7):512-9. PubMed ID: 17576393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple epitopes of hepatitis B virus surface antigen targeted by human plasma-derived immunoglobulins coincide with clinically observed escape mutations.
    Tarafdar S; Virata ML; Yan H; Zhong L; Deng L; Xu Y; He Y; Struble E; Zhang P
    J Med Virol; 2022 Feb; 94(2):649-658. PubMed ID: 34406663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A human monoclonal antibody against small envelope protein of hepatitis B virus with potent neutralization effect.
    Wang W; Sun L; Li T; Ma Y; Li J; Liu Y; Li M; Wang L; Li C; Xie Y; Wen Y; Liang M; Chen L; Tong S
    MAbs; 2016; 8(3):468-77. PubMed ID: 26713590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of a hepatitis B virus neutralizing chimeric monoclonal antibody recognizing escape mutants of the viral surface antigen (HBsAg).
    Golsaz-Shirazi F; Amiri MM; Farid S; Bahadori M; Bohne F; Altstetter S; Wolff L; Kazemi T; Khoshnoodi J; Hojjat-Farsangi M; Chudy M; Jeddi-Tehrani M; Protzer U; Shokri F
    Antiviral Res; 2017 Aug; 144():153-163. PubMed ID: 28641998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in the envelope gene of hepatitis B virus variants co-occurring with antibody to surface antigen in sera from patients with chronic hepatitis B.
    Kohno H; Inoue T; Tsuda F; Okamoto H; Akahane Y
    J Gen Virol; 1996 Aug; 77 ( Pt 8)():1825-31. PubMed ID: 8760433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the antigenic epitopes of hepatitis B surface antigen involved in the induction of a protective antibody response.
    Waters JA; Brown SE; Steward MW; Howard CR; Thomas HC
    Virus Res; 1992 Jan; 22(1):1-12. PubMed ID: 1371369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccine- and hepatitis B immune globulin-induced escape mutations of hepatitis B virus surface antigen.
    Cooreman MP; Leroux-Roels G; Paulij WP
    J Biomed Sci; 2001; 8(3):237-47. PubMed ID: 11385295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a recombinant hepatitis B immunoglobulin derived from B cells collected from healthy individuals administered with hepatitis B virus vaccines: A feasibility study.
    Furuta RA; Yasui T; Minamitani T; Akiba H; Toyoda C; Tobita R; Yasui K; Aminaka R; Masaki M; Satake M
    Transfusion; 2023 Jun; 63(6):1204-1214. PubMed ID: 37119513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the HCV core protein on the immune response to HBV surface antigen and on HBV gene expression and replication in vivo.
    Zhu W; Wu C; Deng W; Pei R; Wang Y; Cao L; Qin B; Lu M; Chen X
    PLoS One; 2012; 7(9):e45146. PubMed ID: 23024803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human monoclonal antibody against Hepatitis B virus surface antigen (HBsAg).
    Shin YW; Ryoo KH; Hong KW; Chang KH; Choi JS; So M; Kim PK; Park JY; Bong KT; Kim SH
    Antiviral Res; 2007 Aug; 75(2):113-20. PubMed ID: 17343928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. De novo activation of HBV with escape mutations from hepatitis B surface antibody after living donor liver transplantation.
    Ueda Y; Marusawa H; Egawa H; Okamoto S; Ogura Y; Oike F; Nishijima N; Takada Y; Uemoto S; Chiba T
    Antivir Ther; 2011; 16(4):479-87. PubMed ID: 21685535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral resistance mutations potentiate hepatitis B virus immune evasion through disruption of its surface antigen a determinant.
    Sloan RD; Ijaz S; Moore PL; Harrison TJ; Teo CG; Tedder RS
    Antivir Ther; 2008; 13(3):439-47. PubMed ID: 18572757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural analysis of hepatitis B surface antigen by monoclonal antibodies.
    Ben-Porath E; Wands JR; Marciniak RA; Wong MA; Hornstein L; Ryder R; Canlas M; Lingao A; Isselbacher KJ
    J Clin Invest; 1985 Oct; 76(4):1338-47. PubMed ID: 2414317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the epitope and neutralizing capacity of human monoclonal antibodies induced by hepatitis B vaccine.
    Tajiri K; Ozawa T; Jin A; Tokimitsu Y; Minemura M; Kishi H; Sugiyama T; Muraguchi A
    Antiviral Res; 2010 Jul; 87(1):40-9. PubMed ID: 20412816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serological detection of hepatitis B virus genotypes by ELISA with monoclonal antibodies to type-specific epitopes in the preS2-region product.
    Usuda S; Okamoto H; Iwanari H; Baba K; Tsuda F; Miyakawa Y; Mayumi M
    J Virol Methods; 1999 Jun; 80(1):97-112. PubMed ID: 10403681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody-mediated immunotherapy against chronic hepatitis B virus infection.
    Gao Y; Zhang TY; Yuan Q; Xia NS
    Hum Vaccin Immunother; 2017 Aug; 13(8):1768-1773. PubMed ID: 28521640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction and expression of hepatitis B surface antigen escape variants within the "a" determinant by site directed mutagenesis.
    Golsaz Shirazi F; Amiri MM; Mohammadi H; Bayat AA; Roohi A; Khoshnoodi J; Zarnani AH; Jeddi-Tehrani M; Kardar GA; Shokri F
    Iran J Immunol; 2013 Sep; 10(3):127-38. PubMed ID: 24076590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro response to HBsAg of peripheral blood lymphocytes from recipients of hepatitis B vaccine.
    Chang TW; Celis E; Miller RW; Zurawski VR; Kung PC
    Hepatology; 1984; 4(5):824-9. PubMed ID: 6207089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.